For the Inventor, By the Inventor

Enter assignee name

Fremont, CA, United States of America

Aryx Therapeutics, Inc.

USPTO Granted Patents = 50

% Expired Patents = 52.0

CIPO Patents = 3

EPO Patents = 2

Forward Citations = 222

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Pascal Jean Druzgala (47 out of 64 patents)

Peter G Milner (19 out of 41 patents)

Cyrus K Becker (14 out of 48 patents)

4. Xiaoming Zhang (9 out of 68 patents)

5. Jurg R Pfister (9 out of 43 patents)

6. Monica H Palme (4 out of 10 patents)

7. Ian Irwin (3 out of 10 patents)

8. Jinun-Ban Yeh (2 out of 10 patents)

9. Courtney Rubens (2 out of 2 patents)

10. Kolbot By (2 out of 2 patents)

11. Ponny Pang (2 out of 2 patents)

12. Jürg Pfister (2 out of 3 patents)

13. Jürg Roland Pfister (2 out of 12 patents)

14. Arthur John Cooper (1 out of 8 patents)

15. Jien-Heh J Tien (1 out of 1 patent)

Core Competencies:

Stereoisomeric Compounds

5-HT3 Receptor Antagonists

Coagulation Disorders

Cardiac Arrhythmia

Ultrashort Acting Opioids

Gastroesophageal Reflux Disease

Depression Treatment

Hypolipidemic Agents

Dibenzo[b,f][1,4]oxazapine

Synthetic Methods

Halogenated Esters

Long-Acting Anesthetics

50 patents: Sort by Forward Citations

1. 8138204 - Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders (2012-03-20),

2. 8093237 - Dibenzo[b,f][1,4]oxazapine compounds (2012-01-10),

3. RE42412 - Materials and methods for the treatment of gastroesophageal reflux disease (2011-05-30),

4. 7932405 - Halogenated ester derivatives of coumarins for the treatment of coagulation disorders (2011-04-26),

5. RE41289 - Ultrashort acting hypnotic barbiturates (2010-04-26),

6. 7666902 - Haloalkyl ester derivatives of coumarin for the treatment of coagulation disorders (2010-02-23),

7. 7629466 - Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders (2009-12-08),

8. 7501436 - 5-HT3 receptor antagonists and methods of use (2009-03-10),

9. 7498449 - Antiarrhythmic precursor compounds, methods of synthesis and methods of use (2009-03-03),

10. 7384973 - Materials and methods for treating hypercholesterolemia (2008-06-10),

11. 7381735 - Ultrashort-acting opioids for transdermal application (2008-06-03),

12. 7351842 - Compounds for treatment of cardiac arrhythmia and methods of use (2008-04-01),

13. 7326787 - Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders (2008-02-05),

14. 7285671 - Materials and methods for treating coagulation disorders (2007-10-23),

15. 7282509 - Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders (2007-10-16),

Company Overview

Aryx Therapeutics, Inc., based in Fremont, CA, specializes in pharmaceutical development with a focus on innovative therapeutic solutions. The company is engaged in the research and development of stereoisomeric compounds and 5-HT3 receptor antagonists, targeting various medical conditions including coagulation disorders, cardiac arrhythmia, and gastroesophageal reflux disease. Aryx is also exploring treatments for depression and hypolipidemic agents, aiming to address significant unmet medical needs through advanced pharmacological approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

50 Patents

#50 in Fremont, CA

#1,646 in California

#6,999 in US

#13,996 in the World

Fremont, CA, United States of America

Aryx Therapeutics, Inc.

Forward Citations = 222

17 inventors:

Pascal Jean Druzgala (47 out of 64 patents)

Peter G Milner (19 out of 41 patents)

Cyrus K Becker (14 out of 48 patents)

4. Xiaoming Zhang (9 out of 68 patents)

5. Jurg R Pfister (9 out of 43 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aryx Therapeutics, Inc.. Retrieved from https://idiyas.com/company/aryx-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…